Quarterly report pursuant to Section 13 or 15(d)

5. Discontinued Operations: Sale of Assets (Details - Discontinued Operations)

v3.20.2
5. Discontinued Operations: Sale of Assets (Details - Discontinued Operations) - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Income from discontinued operations, net of tax $ 949,000 $ 41,000
Micromed Laboratories [Member]    
Revenues 212,000 216,000
Cost of Revenues 53,000 143,000
Selling, general and administrative expenses 5,000 32,000
Income from discontinued operations before tax 154,000 41,000
Gain on disposal of discontinued operations before income taxes 795,000 0
Total income from discontinued operations, before tax 949,000 41,000
Income Tax benefit (expense) 0 0
Income from discontinued operations, net of tax $ 949,000 $ 41,000